on 28 Apr 2022
Last Applicant/ Owned by
F-69003 LYON
FR
Serial Number
79290230 filed on 02th Jul 2020
Registration Number
N/A
Correspondent Address
PRADEEP JAYARAMAN
Filing Basis
No Filing Basis
Disclaimer
NO DATA
Chemical products intended to be integrated in medicines to promote diffusion in a given area of the human body, namely, chemicals preparations for the treatment of diabetes and metabolic diseases; pharmaceutical excipients, namely, chemicals preparations for the treatment of diabetes and metabolic diseases; pharmaceutical preparations for the treatment of diabetes and metabolic diseases UnprocesRead More
Unprocessed chemical polymers for use in the pharmaceutical industries; chemical polymeric additives for use in the pharmaceutical industries
Chemical products intended to be integrated in medicines to promote diffusion in a given area of the human body, namely, chemicals preparations for the treatment of diabetes and metabolic diseases; pharmaceutical excipients, namely, chemicals preparations for the treatment of diabetes and metabolic diseases; pharmaceutical preparations for the treatment of diabetes and metabolic diseases
Research in the medical field; scientific and technological services, namely, design and development of polymers and pharmaceutical excipients for the benefits of third-parties
No 79290230
No Service Mark
No CLV 0822 US
No
No
No
No
No
No
No
No
| Status Date | Action Taken |
|---|---|
| 25th Jun 2022 | OPPOSITION TERMINATED NO. 999999 |
| 25th Jun 2022 | OPPOSITION SUSTAINED NO. 999999 |
| 19th May 2022 | NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED |
| 18th May 2022 | DEATH OF INTERNATIONAL REGISTRATION |
| 15th Jan 2022 | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB |
| 29th Dec 2021 | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB |
| 29th Dec 2021 | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB |
| 08th Nov 2021 | REFUSAL PROCESSED BY IB |
| 15th Oct 2021 | OPPOSITION INSTITUTED NO. 999999 |
| 08th Oct 2021 | OPPOSITION NOTICE (IB REFUSAL) SENT TO IB |
